Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 9, No 1 (2016) COST-EFFECTIVENESS ANALYSIS OF BRENTUXIMAB VEDOTIN IN ADULTS WITH RELAPSED OR REFRACTORY HODGKIN’S LYMPHOMA Abstract  similar documents
G. R. Khachatryan, D. V. Fedyaev, M. V. Avxentyeva, V. S. Dombrovskiy
"... for patients with relapsed or refractory CD30-positive HL after autologous stem cell transplantation (ASCT ..."
 
Vol 8, No 1 (2015) PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION Abstract  similar documents
M. V. Avxentyeva, N. A. Avxentyev, M. Yu. Frolov, E. V. Derkach
"... renal transplantation: everolimus plus reducedexposure cyclosporine and mycophenolic acid plus standard ..."
 
Vol 10, No 2 (2017) PHARMACOECONOMIC ASPECTS OF NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY Abstract  similar documents
A. V. Rudakova, S. A. Protsenko, I. A. Koroleva
"... Treatment of patients with non-small-cell lung cancer (NSCLC) is one of important problems ..."
 
Vol 15, No 1 (2022) The real practice of clinical and economic research of drugs included in the Federal Program of High-Cost Nosologies Abstract  similar documents
A. S. Kolbin, Yu. M. Gomon, A. R. Kasimova, A. A. Kurylev, A. E. Bem
 
Vol 16, No 2 (2023) Key principles of drug therapy in patients with chronic myeloid leukemia Abstract  similar documents
A. V. Zhuravlev, O. I. Knysh
"... therapy, or bone marrow transplantation in the absence of contraindications. Studies are underway ..."
 
Vol 5, No 3 (2012) PHARMACOECONOMIC EVALUATION OF THE MEDICINAL PRODUCTS ERLOTINIB, DOCETAXEL, PEMETREXED AND GEFITINIB IN THE SECOND-LINE TREATMENT OF LOCALLY-ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER Abstract  similar documents
A. U. Kulikov
"... neoplasms in Russia. The diagnosis of a local or metastatic non small cells lung cancer (NSCLC) serves ..."
 
Vol 14, No 2 (2021) Pharmacoeconomic aspects of oral vinorelbine application: a budget impact analysis considering the new registered price Abstract  similar documents
D. A. Ivanov, I. N. Dyakov, S. K. Zyryanov
"... for stage IV non-small-cell lung cancer with oral vinorelbine and pemetrexed as well as first-line ..."
 
Vol 16, No 2 (2023) New pharmacotherapeutic approaches for the treatment of peripheral T-cell lymphoma Abstract  similar documents
M. А. Sorokina, A. V. Rakhteenko, T. R. Grishina
"... -cell lymphomas (PTCL): immunotherapy, including adoptive, targeted therapy and chemotherapy. However ..."
 
Vol 16, No 3 (2023) Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study Abstract  similar documents
A. S. Kolbin, Yu. M. Gomon, M. A. Proskurin, Yu. E. Balykina
"... with lorlatinib in adult patients with advanced anaplastic lymphoma kinase (ALK) positive non-small cell lung ..."
 
Online First Chemoreactome screening of aquacobalamin and heptamethyl ester of cyanoaquacobyrinic acid cytotoxic effects on tumor cells with experimental confirmation on BT-474 and A549 cell lines Abstract  similar documents
I. Yu. Torshin, M. V. Filimonova, O. A. Gromova, L. A. Maiorova, M. A. Sorokina, D. E. Frolova, A. N. Gromov, I. A. Reyer
"... the evaluation of the action of candidate molecules on various types of tumor cells. Vitamin B12 and its ..."
 
Online First Antitumor effects of vitamin B12 in vitro, in vivo, in silico Abstract  similar documents
O. A. Gromova, D. E. Frolova, I. Yu. Torshin, M. V. Filimonova, M. A. Sorokina, I. A. Reyer, O. A. Limanova, L. E. Fedotova, L. A. Maiorova
"... . Cell lines BT-474 (breast ductal carcinoma) and A549 (lung carcinoma) were used as an in vitro cell ..."
 
Vol 10, No 1 (2017) PHARMACOECONOMIC ANALYSIS OF BRENTUXIMAB VEDOTIN THERAPY IN RELAPSED OR REFRACTORY CD30+ SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA IN PATIENTS OVER 18 YEARS OF AGE: HEALTH BUDGET IMPACT ANALYSIS Abstract  similar documents
A. S. Kolbin, I. A. Vilum, М. A. Proskurin, Yu. E. Balykina
"... or refractory CD30+ systemic anaplastic large-cell lymphoma in patients over 18 years of age. Methods ..."
 
Vol 11, No 3 (2018) Ocrelizumab – a monoclonal antibody – in the treatment of adult patients with multiple sclerosis: a systematic review Abstract  similar documents
D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, K. I. Polyakova, A. G. Fisun, K. A. Kokushkin
 
Vol 16, No 3 (2023) Comparative analysis of using atezolizumab vs. durvalumab in combination with platinum-containing chemotherapy in adult patients with advanced small cell lung cancer Abstract  similar documents
I. S. Krysanov, E. V. Makarova, V. Yu. Ermakova
"... with advanced small cell lung cancer (SCLC), but with the advent of new immunological drugs, immune checkpoint ..."
 
Vol 16, No 3 (2023) Updated pharmacoeconomic analysis of atesolizumab efficiency compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy Abstract  similar documents
S. K. Zyryanov, I. N. Dyakov
"... death ligand 1 (PD-L1)) in comparison with other checkpoint inhibitors (inhibitors of programmed cell ..."
 
1 - 15 of 15 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)